Cargando…
The Clinical Utility of Salivary Biomarkers in the Identification of Type 2 Diabetes Risk and Metabolic Syndrome
Type 2 diabetes is traditionally diagnosed by the use of an oral glucose tolerance test and/or HbA1c, both of which require serum collection. Various biomarkers, which are measurable biological substances that provide clinical insight on disease state, have also been effective in the early identific...
Autores principales: | Desai, Priya, Donovan, Lorin, Janowitz, Elizabeth, Kim, Joon Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553598/ https://www.ncbi.nlm.nih.gov/pubmed/33116710 http://dx.doi.org/10.2147/DMSO.S265879 |
Ejemplares similares
-
Incretin Hormones: Pathophysiological Risk Factors and Potential Targets for Type 2 Diabetes
por: Rosenberg, Jared, et al.
Publicado: (2021) -
Salivary uric acid as a noninvasive biomarker of metabolic syndrome
por: Soukup, Maria, et al.
Publicado: (2012) -
Continuous Metabolic Syndrome Scores for Children Using Salivary Biomarkers
por: Shi, Ping, et al.
Publicado: (2015) -
Salivary alpha-amylase–biomarker for monitoring type II diabetes
por: Shah, Vandana S, et al.
Publicado: (2021) -
Dysbiosis of the Salivary Microbiome is Associated with Hypertension and Correlated with Metabolic Syndrome Biomarkers
por: Sohail, Muhammad U, et al.
Publicado: (2021)